2h
WSYR Syracuse on MSNNewly FDA-approved non-opioid painkiller is first of its kind in over 20 yearsFor the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.
By Rick Winterson Vertex Pharmaceuticals is a worldwide biotechnology corporation. It was founded 35 years ago in Cambridge. It has now established its global headquarters on Fan Pier in South ...
The link between acetaminophen and elevated blood pressure is underappreciated. While less common, high blood pressure has ...
Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
FDA approves suzetrigine, a non-opioid painkiller that blocks sodium channels, offering potent relief without addiction risks.
Federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S.
Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about ...
Addiction-free painkiller. Pittsburgh Regional Transit funding. Offices-to-apartments conversion. Brood IX (14).
The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.
Salt Lake County District Attorney Sim Gill has brought sexual assault charges against a former bishop of the Church of Jesus ...
A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...
The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results